What Is New about New Antidepressants?
Author:
Publisher
S. Karger AG
Subject
Psychiatry and Mental health,Applied Psychology,Clinical Psychology,General Medicine
Reference80 articles.
1. Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ: Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind, placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 2012; 69: 572–579.
2. Davey CG, Chanen AM: The unfulfilled promise of the antidepressant medications. Med J Aust 2016; 204: 348–350.
3. Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, Pae CU: Efficacy of antidepressants: bias in randomized clinical trials and related issues. Expert Rev Clin Pharmacol 2018; 11: 15–25.
4. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Aloannidis JP: Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018, DOI: 10.1016/S0140-6736(17)32802-7.
5. Furukawa TA, Cipriani A, Atkinson LZ, Leucht S, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A, Salanti G: Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised studies. Lancet Psychiatry 2016; 3: 1059–1066.
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons;Biology;2024-09-03
2. Care pathways, prescribing practices and treatment outcomes in major depressive disorder and treatment-resistant depression: retrospective, population-based cohort study;BJPsych Open;2024-01
3. Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis;International Clinical Psychopharmacology;2023-02-08
4. The “new wave” of antidepressants: are these agents paradigm-shifters in treating major depression?;Psihiatru.ro;2023
5. Dissecting the molecular mechanisms underlying the antidepressant activities of herbal medicines through the comprehensive review of the recent literatures;Frontiers in Psychiatry;2022-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3